228 related articles for article (PubMed ID: 32118627)
21. Aggressive Plasmablastic Myeloma With Extramedullary Cord Compression and Hyperammonemic Encephalopathy: Case Report and Literature Review.
Dah K; Lavezo JL; Dihowm F
Anticancer Res; 2021 Nov; 41(11):5839-5845. PubMed ID: 34732460
[TBL] [Abstract][Full Text] [Related]
22. Extramedullary disease in multiple myeloma.
Bansal R; Rakshit S; Kumar S
Blood Cancer J; 2021 Sep; 11(9):161. PubMed ID: 34588423
[TBL] [Abstract][Full Text] [Related]
23. [Plasmablastic myeloma initially presented with ascites].
Sato S; Tsunoda S; Kamata W; Tamai Y
Rinsho Ketsueki; 2022; 63(3):194-200. PubMed ID: 35387932
[TBL] [Abstract][Full Text] [Related]
24. Anaplastic myeloma with massive extramedullary involvement. Report of two cases.
Foucar K; Raber M; Foucar E; Barlogie B; Sandler CM; Alexanian R
Cancer; 1983 Jan; 51(1):166-74. PubMed ID: 6336972
[TBL] [Abstract][Full Text] [Related]
25. p53 nuclear accumulation is associated with extramedullary progression of multiple myeloma.
Sheth N; Yeung J; Chang H
Leuk Res; 2009 Oct; 33(10):1357-60. PubMed ID: 19201468
[TBL] [Abstract][Full Text] [Related]
26. Cytogenetics in multiple myeloma patients progressing into extramedullary disease.
Besse L; Sedlarikova L; Greslikova H; Kupska R; Almasi M; Penka M; Jelinek T; Pour L; Adam Z; Kuglik P; Krejci M; Hajek R; Sevcikova S
Eur J Haematol; 2016 Jul; 97(1):93-100. PubMed ID: 26432667
[TBL] [Abstract][Full Text] [Related]
27. Cytogenetic abnormalities correlate with the plasma cell labeling index and extent of bone marrow involvement in myeloma.
Rajkumar SV; Fonseca R; Dewald GW; Therneau TM; Lacy MQ; Kyle RA; Greipp PR; Gertz MA
Cancer Genet Cytogenet; 1999 Aug; 113(1):73-7. PubMed ID: 10459351
[TBL] [Abstract][Full Text] [Related]
28. Extra-skeletal plasmablastic myeloma presenting as palatal growth - An unusual entity.
Kumar S; Bhutani N; Bhargawa S; Kataria SP; Sen R
Int J Surg Case Rep; 2017; 41():423-426. PubMed ID: 29546007
[TBL] [Abstract][Full Text] [Related]
29. Whole-genome optical mapping of bone-marrow myeloma cells reveals association of extramedullary multiple myeloma with chromosome 1 abnormalities.
Kriegova E; Fillerova R; Minarik J; Savara J; Manakova J; Petrackova A; Dihel M; Balcarkova J; Krhovska P; Pika T; Gajdos P; Behalek M; Vasinek M; Papajik T
Sci Rep; 2021 Jul; 11(1):14671. PubMed ID: 34282158
[TBL] [Abstract][Full Text] [Related]
30. Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations.
Fassas AB; Muwalla F; Berryman T; Benramdane R; Joseph L; Anaissie E; Sethi R; Desikan R; Siegel D; Badros A; Toor A; Zangari M; Morris C; Angtuaco E; Mathew S; Wilson C; Hough A; Harik S; Barlogie B; Tricot G
Br J Haematol; 2002 Apr; 117(1):103-8. PubMed ID: 11918539
[TBL] [Abstract][Full Text] [Related]
31. Plasma cell morphology in multiple myeloma and related disorders.
Ribourtout B; Zandecki M
Morphologie; 2015 Jun; 99(325):38-62. PubMed ID: 25899140
[TBL] [Abstract][Full Text] [Related]
32. Cytogenetics of extramedullary manifestations in multiple myeloma.
Billecke L; Murga Penas EM; May AM; Engelhardt M; Nagler A; Leiba M; Schiby G; Kröger N; Zustin J; Marx A; Matschke J; Tiemann M; Goekkurt E; Heidtmann HH; Vettorazzi E; Dierlamm J; Bokemeyer C; Schilling G
Br J Haematol; 2013 Apr; 161(1):87-94. PubMed ID: 23368088
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathologic characteristics of plasma cell myeloma with marrow fibrosis].
Li HL; Ru K; Sun Q; Li ZQ; Zhang HJ; Ma Y; Xian M; Qiu LG; Liu EB
Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):327-331. PubMed ID: 28468039
[No Abstract] [Full Text] [Related]
34. Plasmablastic extramedullary plasmacytoma associated with Epstein-Barr virus arising in an immunocompetent patient with multiple myeloma.
Sasaki S; Hashimoto K; Nakatsuka S; Hasegawa M; Nakano T; Nagata S; Kanakura Y; Hayashi N
Intern Med; 2011; 50(21):2615-20. PubMed ID: 22041368
[TBL] [Abstract][Full Text] [Related]
35. Secondary plasma cell leukaemia (PCL) with plasmablastic morphology.
Xu K; Nacheva E
J Hematop; 2024 Jun; 17(2):117-119. PubMed ID: 38580782
[TBL] [Abstract][Full Text] [Related]
36. Plasmablastic morphology--an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group.
Greipp PR; Leong T; Bennett JM; Gaillard JP; Klein B; Stewart JA; Oken MM; Kay NE; Van Ness B; Kyle RA
Blood; 1998 Apr; 91(7):2501-7. PubMed ID: 9516151
[TBL] [Abstract][Full Text] [Related]
37. Plasmablastic transformation of plasma cell myeloma with heterotropic expression of CD3 and CD4: a case report.
Mishra P; Kakri S; Gujral S
Acta Clin Belg; 2017 Aug; 72(4):250-253. PubMed ID: 27374484
[TBL] [Abstract][Full Text] [Related]
38. Plasmablastic lymphoma with unfavorable chromosomal abnormalities related to plasma cell myeloma: A borderline case between plasmablastic lymphoma and plasmablastic plasma cell myeloma.
Aoyama Y; Tsunemine H; Kodaka T; Oda N; Matsuoka H; Itoh T; Takahashi T
J Clin Exp Hematop; 2017; 57(1):37-39. PubMed ID: 28679965
[No Abstract] [Full Text] [Related]
39. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm.
Dong HY; Scadden DT; de Leval L; Tang Z; Isaacson PG; Harris NL
Am J Surg Pathol; 2005 Dec; 29(12):1633-41. PubMed ID: 16327436
[TBL] [Abstract][Full Text] [Related]
40. Extramedullary Disease in Multiple Myeloma.
Jagosky MH; Usmani SZ
Curr Hematol Malig Rep; 2020 Apr; 15(2):62-71. PubMed ID: 32198576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
